NCT00400426

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: University of Aarhus · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects

Conditions

• Head and Neck Neoplasms
• Recurrence
• Neoplasms, Second Primary

Interventions

Type	Name	Description
PROCEDURE	Radiotherapy	20 Gy in 4 fx

Timeline

• Start date: 2006-11-01
• Primary completion: 2012-06-01
• Completion: 2012-06-01
• First posted: 2006-11-16
• Last updated: 2013-06-19

Locations

1 site across 1 country: Denmark